Ying Xiang

1.9k total citations
53 papers, 1.5k citations indexed

About

Ying Xiang is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Ying Xiang has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Ying Xiang's work include Advanced Glycation End Products research (6 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Xenotransplantation and immune response (5 papers). Ying Xiang is often cited by papers focused on Advanced Glycation End Products research (6 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Xenotransplantation and immune response (5 papers). Ying Xiang collaborates with scholars based in China, United States and Canada. Ying Xiang's co-authors include Leslie L. Robison, Yang Xie, Julie A. Ross, Stella M. Davies, Grace Peng, Gang Chen, Bertha García, Hongtao Sun, Katherine Huppler Hullsiek and Mary van den Berg-Wolf and has published in prestigious journals such as The Lancet, Nature Medicine and Cancer.

In The Last Decade

Ying Xiang

48 papers receiving 1.4k citations

Peers

Ying Xiang
Comparison fields: 5 of 105
  • Surgery 522
  • Molecular Biology 321
  • Infectious Diseases 316
  • Genetics 284
  • Virology 249
Adam M. Zawada Germany
Marlene Antônia dos Reis Brazil
Thanyachai Sura Thailand
Kyrill S. Rogacev Germany
Abraham Majluf‐Cruz Mexico
Thomas Kalb United States
Mathieu Surénaud France
Enrico Brunetta Italy
Jean Dunne Ireland
Christine Modoux Switzerland
Adam M. Zawada Germany View profile →
Citations per field, relative to Ying Xiang
Ying Xiang · 1×
Citations per year, relative to Ying Xiang
Ying Xiang · 1×

Countries citing papers authored by Ying Xiang

Since Specialization
Citations

This map shows the geographic impact of Ying Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xiang more than expected).

Fields of papers citing papers by Ying Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xiang. The network helps show where Ying Xiang may publish in the future.

Co-authorship network of co-authors of Ying Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Xiang. A scholar is included among the top collaborators of Ying Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Xiang. Ying Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Causal influence of immune factors on the risk of diabetic retinopathy: a mendelian randomization study Diabetology & Metabolic Syndrome Yuanyuan Li, Ying Xiang et al. 0
2 Exploring factors influencing the quality of life in diabetes: a network analysis-based study Frontiers in Psychiatry Lu Chen, Ling Li et al. 0
3 Could gastrointestinal tumor-initiating cells originate from cell-cell fusionin vivo? World Journal of Gastrointestinal Oncology Yang Zhou, Jun-Ting Cheng et al. 1
4 Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling Cell Death and Disease Huan Zhao, Huihui Zhang et al. 9
5 Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury Scientific Reports Cheng Fu, Lan Zhu et al. 42
6 Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40 Clinical Immunology Lu Wang, Ying Xiang et al. 15
7 Blockade of Extracellular HMGB1 Suppresses Xenoreactive B Cell Responses and Delays Acute Vascular Xenogeneic Rejection American Journal of Transplantation Bo Zhao, Xuhui Zhu et al. 24
8 Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis Journal of Huazhong University of Science and Technology [Medical Sciences] Lu Wang, Shan Zhong et al. 1
9 Ghrelin inhibits AGEs‐induced apoptosis in human endothelial cells involving ERK1/2 and PI3K/Akt pathways Cell Biochemistry and Function Ying Xiang, Qiang Li et al. 32
10 A Seventeen-Year-Old Female with Hepatosplenic T-cell Lymphoma Associated with Parvoviral Infection Pediatric Reports Ying Xiang, Metin Özdemirli et al. 3
11 Neutralization of the extracellular HMGB1 released by ischaemic-damaged renal cells protects against renal ischaemia-reperfusion injury Nephrology Dialysis Transplantation J. Li, Quan Gong et al. 88
12 Resistance of neonatal porcine Sertoli cells to human xenoantibody and complement-mediated lysis is associated with low expression of α-Gal and high production of clusterin and CD59 Xenotransplantation Lu Wang, Ying Xiang et al. 10
13 Heme oxygenase-1 upregulation significantly inhibits TNF-α and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice International Immunopharmacology Quan Gong, Hui Yin et al. 62
14 Effects of HIV Infection on Body Composition Changes Among Men of Different Racial/Ethnic Origins HIV Clinical Trials Fehmida Visnegarwala, Vaughn Barry et al. 8
15 The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies HIV Clinical Trials Michael J. Kozal, Katherine Huppler Hullsiek et al. 41
16 The Role of Anti-non-Gal Antibodies in the Development of Acute Humoral Xenograft Rejection of hDAF Transgenic Porcine Kidneys in Baboons Receiving Anti-Gal Antibody Neutralization Therapy Transplantation Gang Chen, Hongtao Sun et al. 64
17 A Synergistic Effect Between PG490-88 and Tacrolimus Prolongs Renal Allograft Survival in Monkeys American Journal of Transplantation Huihui Sun, J. Arp et al. 11
18 Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy Clinical Infectious Diseases Richard M. Novak, Rodger D. MacArthur et al. 104
19 Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys Nature Medicine Gang Chen, Hua Qian et al. 289
20 Trends in leukemia incidence and survival in the United States (1973–1998) Cancer Yang Xie, Stella M. Davies et al. 180

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026